ACM
RVMD icon

ADAR1 Capital Management’s Revolution Medicines RVMD Stock Holding History

ADAR1 Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Sell
87,509
-46,384
-35% -$6.78M 0.75% 30
2026
Q1 		$13M Sell
133,893
-11,186
-8% -$1.13M 0.77% 32
2025
Q4 		$11.6M Buy
145,079
+5,943
+4% +$390K 0.85% 31
2025
Q3 		$6.5M Buy
139,136
+5,000
+4% +$196K 0.61% 42
2025
Q2 		$4.93M Sell
134,136
-43,000
-24% -$1.65M 0.76% 34
2025
Q1 		$6.26M Buy
177,136
+7,136
+4% +$290K 1.16% 22
2024
Q4 		$7.44M Buy
170,000
+125,649
+283% +$6.34M 1.49% 14
2024
Q3 		$2.01M Buy
+44,351
New +$1.93M 0.33% 50
2024
Q1 		– Sell
-400
Closed -$11.5K – 284
2023
Q4 		$11.5K Buy
+400
New +$9.61K ﹤0.01% 136

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

ADAR1 Capital Management's RVMD Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Revolution Medicines (RVMD) stake by 35% in Q2 2026, selling an estimated $6.78M and leaving 87,509 shares worth $16.4M. The position accounts for 0.75% of the portfolio, ranked #30.

ADAR1 Capital Management first reported a position in RVMD in Q4 2023 and has held it in 9 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • ADAR1 Capital Management held 87,509 shares of Revolution Medicines worth $16.4M as of Q2 2026.
  • ADAR1 Capital Management sold 46,384 Revolution Medicines shares in Q2 2026, an estimated $6.78M.
  • Revolution Medicines made up 0.75% of ADAR1 Capital Management's portfolio in Q2 2026, its #30 holding.
  • ADAR1 Capital Management first reported a position in Revolution Medicines in Q4 2023 and has held it in 9 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.